Tarai Foods (519285)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹9.99 |
| Market Cap | ₹17.71 Cr |
| P/E Ratio | 0 |
| ROCE | -150% |
| ROE | 17.24% |
| Dividend Yield | 0% |
| Profit Growth | -57.14% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹5.7 — ₹9.99 |
| Sector | Agricultural Food & other Products |
Strengths
- Small ₹18 Cr market cap leaves room for a meaningful per-share recovery if operations ever restart
- Stock trades at 52-week high (₹9.99 vs low ₹5.70), signalling some market interest or turnaround expectations
- Reported ROE of 17.24% is positive, though it conflicts with other weak metrics and needs verification
Concerns
- Latest quarter sales and net profit are ₹0 Cr / ₹-0 Cr, meaning the core business is not generating revenue or earnings
- ROCE of -150% indicates severe capital inefficiency and operating losses
- Profit growth is down 57.14%, sales growth is 0%, and Piotroski F-score is 2/9, showing poor fundamental health
- Book value, P/B, debt/equity, and promoter holding are unavailable, leaving insufficient data for a margin-of-safety valuation
AI Analysis
At ₹9.99, this is a ₹18 Cr microcap with no meaningful earnings. I look first for business quality and a moat. Here I see none. Latest quarter sales are ₹0 Cr and net profit is ₹-0 Cr. ROCE is -150%, which is capital destruction. A Piotroski F-score of 2/9 tells me the fundamentals are deteriorating, not improving. Profit growth has already fallen 57.14%, and sales growth is zero. The reported ROE of 17.24% is an outlier; with book value and debt/equity not available, I cannot trust it or compute a margin of safety. The stock trades at the top of its 52-week range, ₹9.99 versus ₹5.70 low. That is sentiment, not value. Graham would insist on a margin of safety. There is none here. With P/E quoted at 0.00, there are no usable earnings to capitalise. No dividend, no balance-sheet visibility, no promoter data. Even a turnaround, if it ever comes, must be bought at a price that compensates for risk. At this price, the market is paying for a story, not numbers. If the company can restart sales, generate positive operating profit, and show a positive ROCE, then I would study it further. Until then, this is a pass. In the Indian small-cap space, hope is expensive; cash flows are cheap. I need evidence of stability and debt serviceability. None is provided. I would need a clean balance sheet, actual sales, positive free cash flow, and disciplined capital allocation. As Buffett says, 'It's only when the tide goes out that you learn who's been swimming naked.' This company appears to be swimming without data.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer